BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2010
View Archived Issues
Merck & Co.'s new GPR119 agonist lowers blood glucose in murine diabetes model
Read More
Angiochem's EPiC platform yields anticancer drugs with improved brain penetration
Read More
Renovis identifies novel P2X3 and P2X2/3 receptor antagonists
Read More
Janssen discloses novel NOP (ORL1) opioid receptor modulators
Read More
University of Central Florida claims new STAT3 inhibitors
Read More
Novartis presents novel antibacterial agents
Read More
Institute for OneWorld Health claims novel CFTR inhibitors
Read More
AD5-10: new option for treatment of ovarian cancer
Read More
Celgene and Agios collaborate to develop cancer metabolism programs
Read More
Advaxis begins phase II trial of ADXS11-001 in cervical dysplasia
Read More
Impax completes enrollment in phase III IPX-066 trial in Parkinson's disease
Read More
Genocea and U.S. military to collaborate on development of malaria vaccine
Read More
Mirabegron well tolerated and improves overactive bladder variables in large study
Read More
Studies on progesterone caproate for prevention of preterm birth
Read More
Rexahn reports phase IIa Serdaxin data in major depressive disorder
Read More
Impax amends copromotion agreement with Wyeth
Read More
D-Pharm receives agreement letter on SPA for phase III DP-b99 trial in acute ischemic stroke
Read More
Alexion's Soliris approved in Japan for paroxysmal nocturnal hemoglobinuria
Read More
PhytoMedical signs letter of intent with Medicilon for studies on brain cancer drug candidate
Read More
Updated phase I data presented on JI-101 in solid tumors
Read More
Diquas ophthalmic solution approved in Japan for dry eye treatment
Read More
Sandoz to acquire Oriel Therapeutics
Read More
Cell Therapeutics nears MAA submission for pixantrone in E.U.
Read More
FDA approves Tarceva as maintenance therapy for advanced non-small cell lung cancer
Read More
Cannasat Therapeutics becomes Cynapsus Therapeutics
Read More